Medichem, S.A.

medichem.es

Meet an independently-owned developer and manufacturer of Finished Dosage Forms (FDF) , Active Pharmaceutical Ingredients (API) and HPAPI. From its headquarters in Barcelona, Spain, Medichem has grown into one of the largest worldwide manufacturers of Generics and Chlorhexidine in the pharmaceutical industry. Made up of a workforce of 450 talented individuals located in Spain (HQ), the USA, Malta and China, Medichem serves 60 countries worldwide.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical, Industry Outlook

GENEDX ANNOUNCES NEW TOOL TO HELP HARNESS HUMAN PANGENOME DIVERSITY FOR CLINICAL INTERPRETATION OF VARIANTS

Globenewswire | June 27, 2023

news image

GeneDx a leader in delivering improved health outcomes through genomic and clinical insights, today published a paper in Nature Methods, titled “Multiscale analysis of pangenomes enables improved representation of genomic diversity for repetitive and clinically relevant genes,” in which researchers developed a new computational tool, the PanGenome Research-Tool Kit (PGR-TK), for scalable analysis of clinically relevant genes that were previously too complex to analyze. ...

Read More

Cell and Gene Therapy

MATICA BIO ANNOUNCES JOINT RESEARCH AGREEMENT WITH SARTORIUS FOR THE DEVELOPMENT OF ADVANCED VIRAL VECTOR MANUFACTURING TECHNOLOGY

Matica Biotechnology, Inc. | October 19, 2021

news image

Matica Biotechnology, Inc, (Matica Bio) a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, today announced a joint research agreement (JRA) with Sartorius, a leading international partner of the biopharmaceutical industry. Under this agreement, Matica Bio and Sartorius will work on a number of studies together to streamline and optimize PAT technologies, automation software, and single-use platforms offe...

Read More

Medical

STRAMSEN BIOTECH, INC. TO FUND NEXT PHASES OF CLINICAL TRIALS AND ADDITIONAL MEDICINE DISCOVERY RESEARCH

Stramsen Biotech, Inc | December 17, 2020

news image

Stramsen Biotech, Inc, a professional group of medication researchers from the Houston, Texas territory comprises of scientists who devote their lives each day to investigating and exploring both the cycles and logical instruments hidden the world we live in today. Colleagues have gotten a few honors and awards for research ventures, with a significant number of their activities and distributions accessible upon demand. Individuals incorporate PhD and University level professors who specialize i...

Read More

Industrial Impact

PARTEK AND AGILENT PARTNER TO DELIVER ALISSA CUSTOMERS END-TO-END BIOINFORMATICS WORKFLOW

Partek® Incorporated | August 20, 2021

news image

Partek® Incorporated announced today they have entered into an agreement with Agilent to integrate Partek® Flow® bioinformatics software with the Agilent Alissa Clinical Informatics Platform. This integration delivers a complete end-to-end analysis workflow that is robust, flexible, and customizable to meet Agilent customer demands. Partek has also made available the Agilent pipeline for RNA-Seq inside Partek Flow. In addition, the agreement allows Agilent to resell Partek Flow softw...

Read More
news image

Medical, Industry Outlook

GENEDX ANNOUNCES NEW TOOL TO HELP HARNESS HUMAN PANGENOME DIVERSITY FOR CLINICAL INTERPRETATION OF VARIANTS

Globenewswire | June 27, 2023

GeneDx a leader in delivering improved health outcomes through genomic and clinical insights, today published a paper in Nature Methods, titled “Multiscale analysis of pangenomes enables improved representation of genomic diversity for repetitive and clinically relevant genes,” in which researchers developed a new computational tool, the PanGenome Research-Tool Kit (PGR-TK), for scalable analysis of clinically relevant genes that were previously too complex to analyze. ...

Read More
news image

Cell and Gene Therapy

MATICA BIO ANNOUNCES JOINT RESEARCH AGREEMENT WITH SARTORIUS FOR THE DEVELOPMENT OF ADVANCED VIRAL VECTOR MANUFACTURING TECHNOLOGY

Matica Biotechnology, Inc. | October 19, 2021

Matica Biotechnology, Inc, (Matica Bio) a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, today announced a joint research agreement (JRA) with Sartorius, a leading international partner of the biopharmaceutical industry. Under this agreement, Matica Bio and Sartorius will work on a number of studies together to streamline and optimize PAT technologies, automation software, and single-use platforms offe...

Read More
news image

Medical

STRAMSEN BIOTECH, INC. TO FUND NEXT PHASES OF CLINICAL TRIALS AND ADDITIONAL MEDICINE DISCOVERY RESEARCH

Stramsen Biotech, Inc | December 17, 2020

Stramsen Biotech, Inc, a professional group of medication researchers from the Houston, Texas territory comprises of scientists who devote their lives each day to investigating and exploring both the cycles and logical instruments hidden the world we live in today. Colleagues have gotten a few honors and awards for research ventures, with a significant number of their activities and distributions accessible upon demand. Individuals incorporate PhD and University level professors who specialize i...

Read More
news image

Industrial Impact

PARTEK AND AGILENT PARTNER TO DELIVER ALISSA CUSTOMERS END-TO-END BIOINFORMATICS WORKFLOW

Partek® Incorporated | August 20, 2021

Partek® Incorporated announced today they have entered into an agreement with Agilent to integrate Partek® Flow® bioinformatics software with the Agilent Alissa Clinical Informatics Platform. This integration delivers a complete end-to-end analysis workflow that is robust, flexible, and customizable to meet Agilent customer demands. Partek has also made available the Agilent pipeline for RNA-Seq inside Partek Flow. In addition, the agreement allows Agilent to resell Partek Flow softw...

Read More